Leandro Jonata de Carvalho Oliveira
12PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 06, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo
|Jan 30, 2026
Cost-Effectiveness of the Oncotype DX Breast Recurrence Score Test in the Brazilian Private Health Care Sector.Ivan Zimmermann, Carlos Alberto da Silva Magliano, Leandro Jonata de Carvalho Oliveira
|Oct 22, 2025
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira
|Jul 14, 2025
Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2- metastatic breast cancer: clinical and molecular perspectives.Jessé Lopes da Silva, Leandro Jonata de Carvalho Oliveira, Cristiano Augusto Andrade de Resende
|May 24, 2023
Results of a survey study on health professionals' perceptions of tumor boards in Brazil.Thamirys U Menezes, Márcia Mp Serra, Carlos He Barrios
Pageof 2
Frequent Collaborators
8 joint publications
Max Senna Mano
4 joint publications
Tomás Reinert
4 joint publications
Andrea Kazumi Shimada
3 joint publications
Carlos Henrique Dos Anjos
3 joint publications
Daniele Assad-Suzuki
2 joint publications
Cristiano Augusto Andrade de Resende
2 joint publications
Rodrigo Dienstmann
2 joint publications
Carlos He Barrios
2 joint publications
Diocésio Alves Pinto de Andrade
2 joint publications
Carlos Alberto da Silva Magliano